These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 18378573)
1. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Hartnett ME; Martiniuk D; Byfield G; Geisen P; Zeng G; Bautch VL Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3107-14. PubMed ID: 18378573 [TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Geisen P; Peterson LJ; Martiniuk D; Uppal A; Saito Y; Hartnett ME Mol Vis; 2008 Feb; 14():345-57. PubMed ID: 18334951 [TBL] [Abstract][Full Text] [Related]
3. Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats. Nakano A; Nakahara T; Mori A; Ushikubo H; Sakamoto K; Ishii K Exp Eye Res; 2016 Feb; 143():120-31. PubMed ID: 26500193 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity. Wang H; Yang Z; Jiang Y; Flannery J; Hammond S; Kafri T; Vemuri SK; Jones B; Hartnett ME Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):737-44. PubMed ID: 24425858 [TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity. Hartmann JS; Thompson H; Wang H; Kanekar S; Huang W; Budd SJ; Hartnett ME Mol Vis; 2011; 17():1577-87. PubMed ID: 21738387 [TBL] [Abstract][Full Text] [Related]
6. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity. Wang H; Yang Z; Jiang Y; Hartnett ME Mol Vis; 2014; 20():231-41. PubMed ID: 24623966 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Saito Y; Geisen P; Uppal A; Hartnett ME Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545 [TBL] [Abstract][Full Text] [Related]
8. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity. Budd SJ; Thompson H; Hartnett ME Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002 [TBL] [Abstract][Full Text] [Related]
9. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. Saito Y; Uppal A; Byfield G; Budd S; Hartnett ME Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1591-8. PubMed ID: 18385079 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of Retinal Endothelial Vasodilator Function in a Rat Model of Retinopathy of Prematurity. Nakano A; Mori A; Arima S; Asano D; Morita A; Sakamoto K; Nagamitsu T; Nakahara T Curr Eye Res; 2019 Dec; 44(12):1360-1368. PubMed ID: 31317786 [No Abstract] [Full Text] [Related]
11. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. McColm JR; Geisen P; Hartnett ME Mol Vis; 2004 Jul; 10():512-20. PubMed ID: 15303088 [TBL] [Abstract][Full Text] [Related]
12. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR). Scott A; Powner MB; Fruttiger M Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725 [TBL] [Abstract][Full Text] [Related]
13. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity. Budd SJ; Hartnett ME Arch Ophthalmol; 2010 May; 128(5):589-95. PubMed ID: 20457980 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal Delivery of VEGF-A Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455 [TBL] [Abstract][Full Text] [Related]
15. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Hartnett ME; Martiniuk DJ; Saito Y; Geisen P; Peterson LJ; McColm JR Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4975-82. PubMed ID: 17065516 [TBL] [Abstract][Full Text] [Related]
16. Differences between rat strains in models of retinopathy of prematurity. Floyd BN; Leske DA; Wren SM; Mookadam M; Fautsch MP; Holmes JM Mol Vis; 2005 Jul; 11():524-30. PubMed ID: 16052168 [TBL] [Abstract][Full Text] [Related]
17. IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice. Yuan H; Chen S; Duncan MR; de Rivero Vaccari JP; Keane RW; Dalton Dietrich W; Chou TH; Benny M; Schmidt AF; Young K; Park KK; Porciatti V; Elizabeth Hartnett M; Wu S Angiogenesis; 2024 Aug; 27(3):423-440. PubMed ID: 38709389 [TBL] [Abstract][Full Text] [Related]
18. Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. Budd S; Byfield G; Martiniuk D; Geisen P; Hartnett ME Exp Eye Res; 2009 Nov; 89(5):718-27. PubMed ID: 19576214 [TBL] [Abstract][Full Text] [Related]
19. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP. Leske DA; Wu J; Fautsch MP; Karger RA; Berdahl JP; Lanier WL; Holmes JM Mol Vis; 2004 Jan; 10():43-50. PubMed ID: 14758338 [TBL] [Abstract][Full Text] [Related]
20. Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity. Nakano A; Asano D; Kondo R; Mori A; Arima S; Ushikubo H; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T Exp Eye Res; 2018 Mar; 168():115-127. PubMed ID: 29339088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]